Recall D-0541-2026

US Class II Ongoing · initiated 2026-04-24

Recalling firm

Lupin Pharmaceuticals Inc., FL

Product

Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur 441108, INDIA, a) 2 Pens- NDC 70748-346-02; b) 3 Pens - NDC 70748-346-03.

Reason for recall

Presence of particulate matter: a white thread-like structure in the cartridge

← All recalls